Viral subversion of the immune system.

This review describes the diverse array of pathways and molecular targets that are used by viruses to elude immune detection and destruction. These include targeting of pathways for major histocompatibility complex-restricted antigen presentation, apoptosis, cytokine-mediated signaling, and humoral immune responses. The continuous interactions between host and pathogens during their coevolution have shaped the immune system, but also the counter measures used by pathogens. Further study of their interactions should improve our ability to manipulate and exploit the various pathogens.

[1]  H. Thomas,et al.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Cullen,et al.  Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4 , 1997, Journal of virology.

[3]  H. Ploegh,et al.  Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. , 1993, Journal of immunology.

[4]  J. Banchereau,et al.  The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. , 1997, Journal of immunology.

[5]  M. Heise,et al.  The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections , 1995, Journal of virology.

[6]  R. Moyer,et al.  Activation of Caspases in Pig Kidney Cells Infected with Wild-Type and CrmA/SPI-2 Mutants of Cowpox and Rabbitpox Viruses , 1998, Journal of Virology.

[7]  A. Cebrián,et al.  Inhibition of apoptosis by the African swine fever virus Bcl-2 homologue: role of the BH1 domain. , 1997, Virology.

[8]  M. Pandori,et al.  The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. , 1999, Virology.

[9]  A. Berk,et al.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.

[10]  R. Dubose,et al.  The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor , 1998, Journal of Virology.

[11]  E. Kieff,et al.  Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. White,et al.  Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins , 1999, Molecular and Cellular Biology.

[13]  H. Browne,et al.  Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted , 1992, Journal of virology.

[14]  D. Black,et al.  Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. , 1995, Virology.

[15]  M. Foti,et al.  Mechanism of Nef‐induced CD4 endocytosis: Nef connects CD4 with the μ chain of adaptor complexes , 1998, The EMBO journal.

[16]  T. Ranheim,et al.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid , 1996, Journal of virology.

[17]  J. Grundy,et al.  Human Cytomegalovirus Induces an Fe γ Receptor (FcγR) in Endothelial Cells and Fibroblasts that Is Distinct from the Human Cellular FcγRs , 1996 .

[18]  R. Honess,et al.  Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins , 1992, Nature.

[19]  R. Schreiber,et al.  Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 , 1981, The Journal of experimental medicine.

[20]  H. Prentice,et al.  Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. , 1998, Journal of immunology.

[21]  M. A. Jabbar,et al.  Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. , 1997, Virology.

[22]  Stephen J. Elledge,et al.  SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.

[23]  D. Rock,et al.  A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence. , 1997, Virology.

[24]  G. McFadden,et al.  Virus-encoded receptors for cytokines and chemokines. , 1998, Seminars in cell & developmental biology.

[25]  E. Cheng,et al.  Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene , 1997, Journal of virology.

[26]  Jean Gruenberg,et al.  Nef-Induced CD4 Degradation A Diacidic-Based Motif in Nef Functions as a Lysosomal Targeting Signal through the Binding of β-COP in Endosomes , 1999, Cell.

[27]  K. Rock.  A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.

[28]  A. Alcamí,et al.  Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. , 1997, The Journal of general virology.

[29]  E Tom,et al.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.

[30]  J. Mcdougal,et al.  Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. , 1986, Journal of immunology.

[31]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[32]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[33]  R. Benarous,et al.  Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. , 1996, Virology.

[34]  P. Cresswell,et al.  Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells , 1999, Nature Medicine.

[35]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[36]  T. Rapoport,et al.  The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate , 1999, The Journal of cell biology.

[37]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[38]  T. Shenk,et al.  Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product , 1996, Journal of virology.

[39]  G. Sen,et al.  Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein , 1997, Journal of virology.

[40]  L. Payne.  Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. , 1980, The Journal of general virology.

[41]  Tyson V. Sharp,et al.  Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1. , 1999, Virology.

[42]  B. Fleckenstein,et al.  Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri , 1994, Journal of virology.

[43]  D. Wallach,et al.  Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.

[44]  H. Vally,et al.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.

[45]  S. Pierce,et al.  Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1. , 1999, Journal of immunology.

[46]  G. Smith.  Virus proteins that bind cytokines, chemokines or interferons. , 1996, Current opinion in immunology.

[47]  J. Russo,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue , 1997, Nature Medicine.

[48]  G. McFadden,et al.  Immunomodulation by viruses: the myxoma virus story , 1999, Immunological reviews.

[49]  L. Lanier,et al.  Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. , 1996, Journal of immunology.

[50]  A. Alcamí,et al.  Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. , 1998, Journal of immunology.

[51]  J. Hiscott,et al.  Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Jaffe,et al.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.

[53]  T. Farrah,et al.  The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation , 1996, Journal of virology.

[54]  T. Klimkait,et al.  A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.

[55]  H. Chapman,et al.  Endosomal proteolysis and MHC class II function. , 1998, Current opinion in immunology.

[56]  J. Yewdell,et al.  CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.

[57]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[58]  M. Degli-Esposti,et al.  The Murine Cytomegalovirus Chemokine Homolog, m131/129, Is a Determinant of Viral Pathogenicity , 1999, Journal of Virology.

[59]  E. Meinl,et al.  Anti-apoptotic strategies of lymphotropic viruses. , 1998, Immunology today.

[60]  M. Katze,et al.  Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.

[61]  R. Moyer,et al.  DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. , 1993, Virology.

[62]  H. Thomas,et al.  Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy , 1993, Hepatology.

[63]  E. Telford,et al.  The DNA sequence of equine herpesvirus 2. , 1995, Journal of molecular biology.

[64]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[65]  H. Ploegh,et al.  Dislocation of Type I Membrane Proteins from the ER to the Cytosol Is Sensitive to Changes in Redox Potential , 1998, The Journal of cell biology.

[66]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.

[67]  M. Dierich,et al.  Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) , 1996, The Journal of experimental medicine.

[68]  A. Gruhler,et al.  A comparison of viral immune escape strategies targeting the MHC class I assembly pathway , 1999, Immunological reviews.

[69]  E. Kieff,et al.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.

[70]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[71]  H. Ploegh,et al.  The WD‐40 repeat , 1992, FEBS letters.

[72]  G. Nemerow,et al.  Epstein-Barr virus regulates activation and processing of the third component of complement , 1988, The Journal of experimental medicine.

[73]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[74]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[75]  T. Nagashunmugam,et al.  Viral interference with antibody and complement , 1998, Seminars in Cell & Developmental Biology.

[76]  F. Neipel,et al.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.

[77]  R. Eversole,et al.  Multiple anti-cytokine activities secreted from tanapox virus-infected cells. , 1994, Microbial pathogenesis.

[78]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[79]  R. Schlegel,et al.  Vacuolar H+-ATPase Mutants Transform Cells and Define a Binding Site for the Papillomavirus E5 Oncoprotein (*) , 1995, The Journal of Biological Chemistry.

[80]  R. F. Cook,et al.  The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues , 1997, The Journal of experimental medicine.

[81]  B. Roizman,et al.  The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase , 1997 .

[82]  C. Smith,et al.  Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. , 1994, Virology.

[83]  G. Chinnadurai,et al.  Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. , 1994, Virology.

[84]  P. Oostveldt,et al.  Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells , 1997, Journal of virology.

[85]  L. W. Parks,et al.  The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor , 1996, Journal of virology.

[86]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[87]  W. Jefferies,et al.  E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins , 1990, The Journal of experimental medicine.

[88]  G. Sen,et al.  Effects of adenovirus E1A protein on interferon-signaling. , 1996, Virology.

[89]  P. Cresswell,et al.  The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex , 1998, Current Biology.

[90]  R. Means,et al.  A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.

[91]  E. Cheng,et al.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[92]  R. Eisenberg,et al.  Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. , 1997, Journal of immunology.

[93]  G. Johnson,et al.  Intracellular Signaling by the Chemokine Receptor US28 during Human Cytomegalovirus Infection , 1998, Journal of Virology.

[94]  J. Ruby,et al.  Evasion of apoptosis by DNA viruses , 1996, Immunology and cell biology.

[95]  T. Ley,et al.  How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.

[96]  Antonio Alcami,et al.  A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection , 1992, Cell.

[97]  H. Virgin,et al.  Spliced mRNA Encoding the Murine Cytomegalovirus Chemokine Homolog Predicts a β Chemokine of Novel Structure , 1999, Journal of Virology.

[98]  A. Ensser,et al.  Primary structure of the alcelaphine herpesvirus 1 genome , 1997, Journal of virology.

[99]  B. Moss,et al.  Regulation of complement activity by vaccinia virus complement-control protein. , 1992, The Journal of infectious diseases.

[100]  B. Barrell,et al.  Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.

[101]  C. Van Sant,et al.  The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[102]  L. Lopalco,et al.  HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology. , 1995, AIDS research and human retroviruses.

[103]  S. Grzesiek,et al.  The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase , 1996, Nature Structural Biology.

[104]  J. Neefjes,et al.  Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling , 1997 .

[105]  J. Oldridge,et al.  Nef--an adaptor adaptor? , 1998, Trends in cell biology.

[106]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[107]  S. Heath,et al.  Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives , 1997, Immunological reviews.

[108]  B. Barrell,et al.  Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus , 1987, Journal of virology.

[109]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[110]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[111]  J. Atkinson,et al.  Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement- mediated neutralization of viral infectivity , 1987, The Journal of experimental medicine.

[112]  G. McFadden,et al.  Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. , 1999, Virology.

[113]  P. Howley,et al.  The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. , 1992, The EMBO journal.

[114]  C. Ware,et al.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis , 1997, Journal of virology.

[115]  J. Ravetch.  Fc receptors: Rubor redux , 1994, Cell.

[116]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[117]  J. Sodroski,et al.  Decay‐accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement , 1995, European journal of immunology.

[118]  B. McManus,et al.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers , 1997, Journal of virology.

[119]  H. Friedman,et al.  Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity , 1991, Journal of virology.

[120]  J. Yewdell,et al.  The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules , 1997, The Journal of experimental medicine.

[121]  G. Sutter,et al.  Serp2, an Inhibitor of the Interleukin-1β-Converting Enzyme, Is Critical in the Pathobiology of Myxoma Virus , 1998, Journal of Virology.

[122]  R. Plemper,et al.  Retrograde protein translocation: ERADication of secretory proteins in health and disease. , 1999, Trends in biochemical sciences.

[123]  G. McFadden,et al.  The Myxoma Virus-soluble Interferon- Receptor Homolog, M-T7, Inhibits Interferon- in a Species-specific Manner (*) , 1995, The Journal of Biological Chemistry.

[124]  K. Kitajima,et al.  Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation. , 1994, The Journal of biological chemistry.

[125]  P. Spear,et al.  Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein , 1982, Journal of virology.

[126]  A. Hasegawa,et al.  Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. , 1999, Journal of immunology.

[127]  S. Morrison,et al.  Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G* , 1999, The Journal of Biological Chemistry.

[128]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[129]  E. Kieff,et al.  BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication , 1991, Journal of virology.

[130]  L. Moretta,et al.  The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. , 1999, International immunology.

[131]  P. Openshaw,et al.  Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. , 1998, The Journal of general virology.

[132]  A. Mantovani,et al.  Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. , 1998, Journal of immunology.

[133]  R. Welsh,et al.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo , 1985, The Journal of experimental medicine.

[134]  D. Lowy,et al.  The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors , 1989, Cell.

[135]  B. Woda,et al.  Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. , 1983, Journal of immunology.

[136]  Y. Li,et al.  Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers , 1997, Journal of virology.

[137]  P. Pitha,et al.  Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). , 1999, Journal of human virology.

[138]  R. Burton,et al.  The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. , 1992, Journal of immunology.

[139]  G. McFadden,et al.  Apoptosis regulators from DNA viruses. , 1998, Current opinion in immunology.

[140]  P. Cresswell,et al.  Association of human class I MHC alleles with the adenovirus E3/19K protein. , 1994, Journal of immunology.

[141]  H. Virgin,et al.  Murine Gammaherpesvirus 68 Encodes a Functional Regulator of Complement Activation , 1999, Journal of Virology.

[142]  Mike Rothe,et al.  The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.

[143]  J. Yewdell,et al.  Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation , 1991, The Journal of experimental medicine.

[144]  M. Daëron,et al.  Fc receptor biology. , 2003, Annual review of immunology.

[145]  Stefan Imreh,et al.  A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: a new mechanism for selective inhibition of proteolysis , 1998, Nature Medicine.

[146]  L. Yu,et al.  The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. , 1999, Journal of immunology.

[147]  D. Trono,et al.  The downregulation of CD4 and MHC‐I by primate lentiviruses: a paradigm for the modulation of cell surface receptors , 1999, Immunological reviews.

[148]  A Ciechanover,et al.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[149]  S. Le Gall,et al.  Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. , 1998, Immunity.

[150]  M. Jackson,et al.  Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. , 1990, The EMBO journal.

[151]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[152]  C. Smith,et al.  Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. , 1996, Virology.

[153]  Y. Tanaka,et al.  Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis. , 1988, Virology.

[154]  B. Woda,et al.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice , 1984, Journal of virology.

[155]  A. Sette,et al.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.

[156]  S. Grzesiek,et al.  The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. , 1996, Biochemistry.

[157]  J. Skowroński,et al.  Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling , 1997, The EMBO journal.

[158]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[159]  G. Bancroft,et al.  Increased susceptibility to cytomegalovirus infection in beige mutant mice. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[160]  W. Jackson,et al.  Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI , 1992, Journal of virology.

[161]  P. A. Peterson,et al.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. , 1996, The EMBO journal.

[162]  K. Siminovitch,et al.  Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. , 1995, Science.

[163]  Geoffrey L. Smith,et al.  Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. , 1991, The Journal of general virology.

[164]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[165]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[166]  H. Ploegh,et al.  Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. , 1996, Journal of immunology.

[167]  P. Branton,et al.  Adenovirus E1B 19-kDa Death Suppressor Protein Interacts with Bax but Not with Bad* , 1996, The Journal of Biological Chemistry.

[168]  P. Bjorkman,et al.  Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. , 1994, Immunity.

[169]  Geoffrey L. Smith,et al.  The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. , 1993, Virology.

[170]  Y. Hannun,et al.  Cytokine response modifier A (CrmA): a strategically deployed viral weapon. , 1998, Clinical immunology and immunopathology.

[171]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[172]  J. Lubinski,et al.  In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor , 1998, Journal of Virology.

[173]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.

[174]  R. Buller,et al.  Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein , 1992, Cell.

[175]  S. Riddell,et al.  Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus , 1993, Journal of virology.

[176]  M. Berry,et al.  Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. , 1998, Science.

[177]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[178]  G. McFadden,et al.  The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. , 1997, Virology.

[179]  A. Enk,et al.  IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. , 1995, Journal of immunology.

[180]  M. Rowe,et al.  Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[181]  G. McFadden,et al.  The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines , 1997, Journal of virology.

[182]  B. Fleckenstein,et al.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. , 1987, The Journal of general virology.

[183]  Rinaldo Cr.  Modulation of major histocompatibility complex antigen expression by viral infection. , 1994 .

[184]  S. Riddell,et al.  Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product , 1996, Nature.

[185]  É. Cohen,et al.  Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule , 1997, Journal of virology.

[186]  H. Ploegh,et al.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. , 1995, Annual review of cell and developmental biology.

[187]  T. Shenk,et al.  Human cytomegalovirus IE1 and IE2 proteins block apoptosis. , 1995, Journal of virology.

[188]  G. McFadden,et al.  Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition , 1997, Journal of virology.

[189]  M. Carroll,et al.  The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.

[190]  D. Schomburg,et al.  Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. , 2009, International journal of peptide and protein research.

[191]  C. Speth,et al.  Modulation of cell surface protein expression by infection with HIV-1 , 1999, Leukemia.

[192]  Jian Kang,et al.  Interaction of an Adenovirus E3 14.7-Kilodalton Protein with a Novel Tumor Necrosis Factor Alpha-Inducible Cellular Protein Containing Leucine Zipper Domains , 1998, Molecular and Cellular Biology.

[193]  J. Bertin,et al.  Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses , 1997, Journal of virology.

[194]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[195]  J. Hiscott,et al.  Triggering the interferon response: the role of IRF-3 transcription factor. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[196]  S. K. Saha,et al.  The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor , 1991, Journal of virology.

[197]  Geoffrey L. Smith,et al.  Vaccinia virus immune evasion. , 1999, Immunology letters.

[198]  Sarah Rowland-Jones,et al.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.

[199]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[200]  M. Heise,et al.  Murine Cytomegalovirus Inhibits Interferon γ–induced Antigen Presentation to CD4 T Cells by Macrophages Via Regulation of Expression of Major Histocompatibility Complex Class II–associated Genes , 1998, The Journal of experimental medicine.

[201]  K. Jeang,et al.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.

[202]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[203]  G. McFadden,et al.  Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. , 1991, Virology.

[204]  A. Elsing,et al.  The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[205]  F. Bloom,et al.  Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[206]  B. Fleckenstein,et al.  The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity , 1995, Journal of virology.

[207]  M. Endres,et al.  The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8 , 1999, The Journal of experimental medicine.

[208]  Yen-Liang Chen,et al.  Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking , 1999, Journal of Virology.

[209]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[210]  G. F. Burton,et al.  Follicular dendritic cells and human immunodeficiency virus infectivity , 1995, Nature.

[211]  E. Paoletti,et al.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[212]  P. Latreille,et al.  Complete sequence and genomic analysis of murine gammaherpesvirus 68 , 1997, Journal of virology.

[213]  M. Greenberg,et al.  A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4 , 1998, Current Biology.

[214]  F. Khanim,et al.  BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. , 1997, The Journal of general virology.

[215]  B. Barrell,et al.  Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus , 1997, Journal of virology.

[216]  T. Hanke,et al.  Cloning of a mouse homolog of CD94 extends the family of C‐type lectins on murine natural killer cells , 1997, European journal of immunology.

[217]  F. Brodsky,et al.  Human pathogen subversion of antigen presentation , 1999, Immunological reviews.

[218]  M. Smyth,et al.  M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.

[219]  L. Shultz,et al.  Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. , 1994, Natural immunity.

[220]  T. Schall,et al.  Chemokines, leukocyte trafficking, and inflammation. , 1994, Current opinion in immunology.

[221]  T. Graf,et al.  Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and Bak , 1999, Journal of Virology.

[222]  F. Chisari,et al.  To kill or to cure: options in host defense against viral infection. , 1996, Current opinion in immunology.

[223]  P. Simmonds,et al.  HIV-1 tropism and co-receptor use , 1997, Nature.

[224]  D. Devine,et al.  Altered expression of host‐encoded complement regulators on human cytomegalovirus‐infected cells , 1996, European journal of immunology.

[225]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[226]  P. Secchiero,et al.  Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels. , 1997, Journal of immunology.

[227]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[228]  W. Wold,et al.  Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus , 1989, Cell.

[229]  D. Wallach,et al.  Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .

[230]  H. Friedman,et al.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G , 1989, Journal of virology.

[231]  W. Wold,et al.  Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.

[232]  M. K. Spriggs.  Virus-encoded modulators of cytokines and growth factors. , 1999, Cytokine & growth factor reviews.

[233]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[234]  C. Bruggeman,et al.  The R33 G Protein-Coupled Receptor Gene of Rat Cytomegalovirus Plays an Essential Role in the Pathogenesis of Viral Infection , 1998, Journal of Virology.

[235]  F. Takei,et al.  Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. , 1998, Cellular immunology.

[236]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[237]  V. Koistinen,et al.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. , 1993, Immunology.

[238]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[239]  G. McFadden,et al.  The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. , 1997, Virology.

[240]  G. McFadden,et al.  Species Specificity of Ectromelia Virus and Vaccinia Virus Interferon-γ Binding Proteins , 1995 .

[241]  B. Fleckenstein,et al.  Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. , 1992, Virology.

[242]  M. Gerhart,et al.  Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. , 1997, Virology.

[243]  P. A. Peterson,et al.  A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum , 1987, Cell.

[244]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[245]  S. Benichou,et al.  Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. , 1994, The Journal of biological chemistry.

[246]  U. Koszinowski,et al.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.

[247]  P. Åman,et al.  An Epstein‐Barr virus immortalization associated gene segment interferes specifically with the IFN‐induced anti‐proliferative response in human B‐lymphoid cell lines. , 1990, The EMBO journal.

[248]  I. Kerr,et al.  Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. , 1984, European journal of biochemistry.

[249]  J. Hiscott,et al.  Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation , 1998, Molecular and Cellular Biology.

[250]  U. Koszinowski,et al.  Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. , 1996, The Journal of general virology.

[251]  T. Jackson.  Transport vesicles: Coats of many colours , 1998, Current Biology.

[252]  D. Sedmak,et al.  Human Cytomegalovirus Inhibits IFN-α-Stimulated Antiviral and Immunoregulatory Responses by Blocking Multiple Levels of IFN-α Signal Transduction , 1999, The Journal of Immunology.

[253]  T. Kirchhausen,et al.  Interaction of the Bovine Papillomavirus E6 Protein with the Clathrin Adaptor Complex AP-1 , 1998, Journal of Virology.

[254]  N. Lurain,et al.  Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). , 1995, Journal of immunology.

[255]  N. Heveker,et al.  Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. , 1997, Science.

[256]  J. Corbeil,et al.  Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. , 1999, Journal of immunology.

[257]  M. Greenberg,et al.  Two elements target SIV Nef to the AP‐2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis , 1999, The EMBO journal.

[258]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[259]  E. Geras-Raaka,et al.  Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor , 1998, The Journal of experimental medicine.

[260]  M. Spriggs,et al.  One step ahead of the game: viral immunomodulatory molecules. , 1996, Annual review of immunology.

[261]  S. Shchelkunov,et al.  The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. , 1997, Virology.

[262]  N. Horikoshi,et al.  Oncogenic potential of the adenovirus E4orf6 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[263]  G. McFadden,et al.  Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. , 1996, Virology.

[264]  T. Shenk,et al.  Human Cytomegalovirus Inhibits Transcription of the CC Chemokine MCP-1 Gene , 1999, Journal of Virology.

[265]  J. Schmitz,et al.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. , 1995, The Journal of clinical investigation.

[266]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[267]  N. Davis-Poynter,et al.  From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunity. , 1998, Seminars in cell & developmental biology.

[268]  P. Murphy,et al.  Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. , 1993, The Journal of biological chemistry.

[269]  H. Kung,et al.  Transforming Potential of the Herpesvirus Oncoprotein MEQ: Morphological Transformation, Serum-Independent Growth, and Inhibition of Apoptosis , 1998, Journal of Virology.

[270]  M. Pandori,et al.  Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[271]  L. Björck,et al.  The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors. , 1989, Journal of immunology.

[272]  D. Trono,et al.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner , 1999, Current Biology.

[273]  J. Yates,et al.  BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro , 1992, Journal of virology.

[274]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[275]  J. Panus,et al.  A third distinct tumor necrosis factor receptor of orthopoxviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[276]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.

[277]  Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. , 1998 .

[278]  M. Hannink,et al.  Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes , 1997, Journal of virology.

[279]  G. Otting,et al.  Random coil conformation of a Gly/Ala‐rich insert in IκBα excludes structural stabilization as the mechanism for protection against proteasomal degradation , 1998 .

[280]  R. Black,et al.  Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[281]  L. Miller.  Baculovirus interaction with host apoptotic pathways , 1997, Journal of cellular physiology.

[282]  S. Beck,et al.  A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin , 1990, Nature.

[283]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[284]  David C. Johnson,et al.  Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. , 1993, The Journal of infectious diseases.

[285]  R L Ashley,et al.  The acquisition of herpes simplex virus during pregnancy. , 1997, The New England journal of medicine.

[286]  T. Schwartz,et al.  A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.

[287]  E. E. Avila,et al.  Antibody-induced caps in Entamoeba histolytica: isolation and electrophoretic analysis. , 1986, The Journal of infectious diseases.

[288]  B. Moss,et al.  Inhibition of the complement cascade by the major secretory protein of vaccinia virus. , 1990, Science.

[289]  M. Lenburg,et al.  Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain , 1994, Cell.

[290]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[291]  P. Lachmann,et al.  Complement and immunity to viruses , 1997, Immunological reviews.

[292]  J. Schifferli,et al.  Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS , 1994, European journal of immunology.

[293]  V. Dixit,et al.  A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[294]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[295]  P. Branton,et al.  Regulation of apoptosis by viral gene products , 1997, Journal of virology.

[296]  G. Trinchieri,et al.  Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.

[297]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[298]  A. Alcamí,et al.  Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity , 1995, Journal of virology.

[299]  J. Pieters.  MHC class II restricted antigen presentation. , 1997, Current opinion in immunology.

[300]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[301]  H. W. Chang,et al.  The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms , 1993, Journal of virology.

[302]  R. Dubose,et al.  A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. , 1998, Immunity.

[303]  W. Greene,et al.  A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor , 1998, Current Biology.

[304]  P. A. Peterson,et al.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[305]  M. Greenberg,et al.  The SH3 domain‐binding surface and an acidic motif in HIV‐1 Nef regulate trafficking of class I MHC complexes , 1998, The EMBO journal.

[306]  A. Mercer,et al.  A homolog of interleukin-10 is encoded by the poxvirus orf virus , 1997, Journal of virology.

[307]  S. Shchelkunov,et al.  Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat , 1998, Journal of leukocyte biology.

[308]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[309]  U. Koszinowski,et al.  Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor , 1994, Journal of virology.

[310]  G. Hayward,et al.  Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.

[311]  M. Mathews,et al.  Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. , 1995, RNA.

[312]  A. Abbas,et al.  Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. , 1998, Journal of immunology.

[313]  S. Akira,et al.  Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.

[314]  B. Moss,et al.  Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope , 1992, Journal of virology.

[315]  B. Barrell,et al.  Analysis of the complete DNA sequence of murine cytomegalovirus , 1996, Journal of virology.

[316]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[317]  M. Greenberg,et al.  Co‐localization of HIV‐1 Nef with the AP‐2 adaptor protein complex correlates with Nef‐induced CD4 down‐regulation , 1997, The EMBO journal.

[318]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[319]  C. Hutchison,et al.  The DNA sequence of the human cytomegalovirus genome. , 1991, DNA sequence : the journal of DNA sequencing and mapping.

[320]  A. Milon,et al.  Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme , 1996, Journal of virology.

[321]  J. Boss.  Regulation of transcription of MHC class II genes. , 1997, Current opinion in immunology.

[322]  M. Mathews,et al.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach , 1996, Journal of virology.

[323]  A. Landay,et al.  Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. , 1995, Clinical immunology and immunopathology.

[324]  L. Arthur,et al.  HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. , 1989, Journal of immunology.

[325]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[326]  P. Åman,et al.  The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3 , 1992, Molecular and cellular biology.

[327]  G. McFadden,et al.  Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes , 1995, Journal of virology.

[328]  M. Dierich,et al.  Interaction of several complement proteins with gp120 and gp41, the two envelope gycoproteins of HIV‐1 , 1995, AIDS.

[329]  K. Matsumoto,et al.  Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[330]  P. Bjorkman,et al.  Characterization of a Murine Cytomegalovirus Class I Major Histocompatibility Complex (MHC) Homolog: Comparison to MHC Molecules and to the Human Cytomegalovirus MHC Homolog , 1998, Journal of Virology.

[331]  K. Ozato,et al.  Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor , 1998, Journal of Virology.

[332]  J. Said,et al.  Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. , 1997, Science.

[333]  M. Foti,et al.  The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. , 1997, Immunity.

[334]  P. Farrell.  Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. , 1998, Trends in microbiology.

[335]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[336]  D. Andrews,et al.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes , 1994, Cell.

[337]  M. Hurme,et al.  Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. , 1999, The Journal of infectious diseases.

[338]  P. Allavena,et al.  The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.

[339]  B. Hogue,et al.  Molecular mimicry between Fc receptor and S peplomer protein of mouse hepatitis virus, bovine corona virus, and transmissible gastroenteritis virus. , 1995, Hybridoma.

[340]  T. Watts,et al.  Molecular chaperones in antigen presentation. , 1995, Current opinion in immunology.

[341]  E. Geras-Raaka,et al.  Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. , 1998, Biochemical and biophysical research communications.

[342]  C. Karp.  Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.

[343]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[344]  E. Koonin,et al.  Genome Sequence of a Human Tumorigenic Poxvirus: Prediction of Specific Host Response-Evasion Genes , 1996, Science.

[345]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[346]  L. Gooding,et al.  Immune evasion by adenoviruses , 1999, Immunological reviews.

[347]  T. Schall,et al.  Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[348]  F. Maldarelli,et al.  Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein , 1993, Journal of virology.

[349]  H. Ploegh,et al.  Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11 , 1998, The Journal of experimental medicine.

[350]  W. Rozenbaum,et al.  Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. , 1987, AIDS.

[351]  H. Ploegh,et al.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.

[352]  A. Strasser,et al.  Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death , 1997, Oncogene.

[353]  K. Rosenthal,et al.  Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus. , 1993, Journal of immunology.

[354]  K. Yamanishi,et al.  Human Herpesvirus 6 Open Reading Frame U83 Encodes a Functional Chemokine , 1999, Journal of Virology.

[355]  D. Fearon.  The complement system and adaptive immunity. , 1998, Seminars in immunology.

[356]  M. Rocchi,et al.  The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. , 1998, Journal of immunology.

[357]  U. Schubert,et al.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.

[358]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[359]  S. Zolla-Pazner,et al.  Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.

[360]  R. Welsh,et al.  Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function , 1991, The Journal of experimental medicine.

[361]  R. Redfield,et al.  Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[362]  P. van Oostveldt,et al.  Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. , 1999, The Journal of general virology.

[363]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[364]  J. Tschopp,et al.  The fight of viruses against apoptosis. , 1998, Current opinion in genetics & development.

[365]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[366]  M. Mann,et al.  ER‐60, a chaperone with thiol‐dependent reductase activity involved in MHC class I assembly , 1998, The EMBO journal.

[367]  H. Ploegh,et al.  Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47 , 1998, Journal of Virology.

[368]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[369]  J. Bruder,et al.  Interaction of the Adenovirus 14.7-kDa Protein with FLICE Inhibits Fas Ligand-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[370]  V. Fischetti,et al.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[371]  H. Burgert,et al.  The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. , 1987, The EMBO journal.

[372]  C. Rivas,et al.  African Swine Fever Virus GeneA179L,a Viral Homologue ofbcl-2, Protects Cells from Programmed Cell Death , 1996 .

[373]  H. W. Chang,et al.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[374]  G. Carpenter,et al.  Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism , 1992, Journal of cellular physiology.

[375]  Robert B Sim,et al.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[376]  F. Almazán,et al.  The African swine fever virus IAP homolog is a late structural polypeptide. , 1995, Virology.

[377]  T. Schall,et al.  HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8 , 1999, The Journal of Biological Chemistry.

[378]  K. Früh,et al.  Herpes Simplex Virus Type 2 ICP47 Inhibits Human TAP but Not Mouse TAP , 1998, Journal of Virology.

[379]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[380]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[381]  A. Alcamí,et al.  Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. , 1999, The Journal of general virology.

[382]  J. Verhoef,et al.  Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells. , 1992, Immunology.

[383]  C. Vita,et al.  Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.

[384]  B. Pedersen,et al.  Clinical Progression of HIV Infection: Role of NK Cells , 1997, Scandinavian journal of immunology.

[385]  N. Stow,et al.  Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI , 1988, Journal of virology.

[386]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[387]  F. Brodsky,et al.  Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. , 1998, Immunity.

[388]  John D Lambris,et al.  Immune evasion properties of herpes simplex virus type 1 glycoprotein gC , 1996, Journal of virology.

[389]  M. Androlewicz,et al.  Herpes Simplex Virus Inhibitor ICP47 Destabilizes the Transporter Associated with Antigen Processing (TAP) Heterodimer* , 1998, The Journal of Biological Chemistry.

[390]  S. Burrows,et al.  Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. , 1995, Virology.

[391]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[392]  J. Marsh,et al.  The numerous effector functions of Nef. , 1999, Archives of biochemistry and biophysics.

[393]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[394]  B. Cullen,et al.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein , 1999, Current Biology.

[395]  P. Spear,et al.  Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein , 1979, Journal of virology.

[396]  B. Moss,et al.  Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[397]  D. Sedmak,et al.  Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway , 1998, The Journal of experimental medicine.

[398]  P. Doherty,et al.  Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells , 1998, Nature.

[399]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[400]  John D Lambris,et al.  Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. , 1998, Journal of immunology.

[401]  H. Ploegh,et al.  The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[402]  J. Sodroski,et al.  Identification of a protein encoded by the vpu gene of HIV-1 , 1988, Nature.

[403]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.